missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ dATP (10 mM)
Invitrogen dATP is prepared to a final concentration of 10 mM in 0.9 mM Tris-HCl at pH 7.5.
Brand: Invitrogen™ 18252015
88.80 EUR valid until 2024-12-31
Use promo code "21651" to get your promotional price.
Includes: Supplied at a concentration of 10mM in Tris-HCl (pH 7.5). The 10mM dNTP Mix contains all four of the dNTPs, each at a final concentration of 10mM.
Description
Invitrogen dATP is prepared to a final concentration of 10 mM in 0.9 mM Tris-HCl at pH 7.5. 10 mM dATP is suitable for use in a wide variety of molecular biology applications including: polymerase chain reaction (PCR), sequencing, fill-in reactions, nick translation, cDNA synthesis, and TdT-tailing reactions.
Invitrogen dNTP nucleotides are manufactured in Class D clean rooms under ISO 9001 standards and supplied in a convenient, ready-to-use format
Features include:
• Chemically synthesized
• >99% purity confirmed by HPLC
• Stable for 2 years at –20°C
• Free from qPCR, PCR, reverse transcription inhibitors
• Free of DNases and RNases
• Free of human and E. coli DNA
Applications
• qPCR, RT-qPCR
• PCR, RT-PCR, cDNA synthesis
• High-fidelity and long-range PCR
• Isothermal amplification
• DNA labeling
• Cloning
• Sanger and next-generation sequencing (NGS)
Related products
• 10 mM dCTP (Cat. No. 18253013)
• 10 mM dGTP (18254011)
• 10 mM dTTP (18255018)
Thermo Fisher Scientific offers a wide variety of dNTPs in different concentrations, volumes, and formats.
Order Info
Approved for shipment on Wet or Dry Ice
Specifications
| 10 mM dATP in Tris-HCl (250 μL) Store at –20°C. |
|
| Unlabeled | |
| Approved for shipment on Wet or Dry Ice | |
| 10 mM |
| Liquid | |
| 250 μL | |
| Standard PCR, Real Time PCR (qPCR), Isothermal Amplification |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only. Not for use in diagnostic procedures.
Spot an opportunity for improvement?Share a Content Correction